Helmut Zarbl

Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae.

Quantitative detection of benzo[alpha]pyrene diolepoxide-DNA adducts by cryogenic laser induced fluorescence.

A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.

Frequent activation of CArG binding factor-A expression and binding in N-methyl-N-nitrosourea-induced rat mammary carcinomas.

GENE impedance: a natural process for control of gene expression and the origin of RNA interference.

Phenotypic anchoring of global gene expression profiles induced by N-hydroxy-4-acetylaminobiphenyl and benzo[a]pyrene diol epoxide reveals correlations between expression profiles and mechanism of toxicity.

Standardizing global gene expression analysis between laboratories and across platforms.

Expression of a human cytochrome p450 in yeast permits analysis of pathways for response to and repair of aflatoxin-induced DNA damage.

Analysis of cellular responses to aflatoxin B(1) in yeast expressing human cytochrome P450 1A2 using cDNA microarrays.

Distributions of five common point mutants in the human tracheal-bronchial epithelium.

Quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human lymphoblastoid TK6 cells dosed with N-hydroxy-4-acetylaminobiphenyl and their relationship to mutation, toxicity, and gene expression profiling.

Dickkopf-1 activates cell death in MDA-MB435 melanoma cells.

Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture.

Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues.

Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses.

Comparative genomics of susceptibility to mammary carcinogenesis among inbred rat strains: role of reduced prolactin signaling in resistance of the Copenhagen strain.

Toxicogenomic analyses of genetic susceptibility to mammary gland carcinogenesis in rodents: implications for human breast cancer.

Dickkopf-1 mediated tumor suppression in human breast carcinoma cells.

Fetal-juvenile origins of point mutations in the adult human tracheal-bronchial epithelium: absence of detectable effects of age, gender or smoking status.

Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue.

The vanishing zero revisited: thresholds in the age of genomics.

Methylselenocysteine resets the rhythmic expression of circadian and growth-regulatory genes disrupted by nitrosomethylurea in vivo.

The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner.

Urinary mycoestrogens, body size and breast development in New Jersey girls.

Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells.

Mapping of Mcs30, a new mammary carcinoma susceptibility quantitative trait locus (QTL30) on rat chromosome 12: identification of fry as a candidate Mcs gene.

Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: application to the Jersey girl study.

Epigenetic Regulation of Dopamine Transporter mRNA Expression in Human Neuroblastoma Cells.

Sleep interruption associated with house staff work schedules alters circadian gene expression.

Enhancement of NAD⁺-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells.

Tracking matrix effects in the analysis of DNA adducts of polycyclic aromatic hydrocarbons.

World Trade Center (WTC) dust exposure in mice is associated with inflammation, oxidative stress and epigenetic changes in the lung.

Uncoupling genotoxic stress responses from circadian control increases susceptibility to mammary carcinogenesis.

Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.